Detalles de la búsqueda
1.
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials.
Crit Care
; 28(1): 92, 2024 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38515121
2.
Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: a report from the 2020 Kidney Disease Clinical Trialists meeting.
Nephrol Dial Transplant
; 38(4): 834-844, 2023 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35022767
3.
Optimizing the Design and Analysis of Future AKI Trials.
J Am Soc Nephrol
; 33(8): 1459-1470, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35831022
4.
Epidemiology and genetics of cystic fibrosis in Asia: In preparation for the next-generation treatments.
Respirology
; 20(8): 1172-81, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26437683
5.
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
Intensive Care Med
; 50(1): 68-78, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38172296
6.
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury.
BMJ Open
; 13(4): e065613, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012016
7.
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
Intensive Care Med
; 50(4): 614-615, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38436728
Resultados
1 -
7
de 7
1
Próxima >
>>